Astral (ASTRAL) Q3 24/25 earnings summary

Executive summary

• Achieved consolidated top-line growth of 2% and EBITDA growth of 9.3% year-over-year despite industry headwinds and demand challenges in Q3 FY25.

• Board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024.

• Results reviewed by Audit Committee and statutory auditors, with no material misstatements identified.

• Maintained strong margins in core segments, focusing on value-added and quality products, and expanded product certifications and launches.

• Continued expansion in bathware, adhesives, and paint, with new product launches and geographic penetration.

Financial highlights

• Q3 consolidated sales: INR 1,397 crore; pipe: INR 990 crore, paint: INR 50 crore, adhesive: INR 280 crore, UK: INR 77 crore.

• Standalone Q3 FY25 revenue from operations: Rs 12,705 million, up from Rs 12,429 million YoY; net profit: Rs 1,259 million, up from Rs 1,201 million YoY.

• Consolidated Q3 FY25 revenue from operations: Rs 13,970 million, up from Rs 13,702 million YoY; net profit: Rs 1,126 million, down from Rs 1,253 million YoY.

• EBITDA margin: pipe 18.47%, paint 4%, adhesive India 16.36%, adhesive UK 0.65%, consolidated 16.5%.

• Bathware Q3 sales: INR 27.9 crore, up 48% YoY; nine-month bathware sales: INR 83 crore.

Outlook and guidance

• Volume growth guidance for next year: 10%-15%, with potential for higher if market conditions improve.

• Focus remains on volume growth over margin expansion in pipes; margin range to be maintained at 16%-18%.

• Paint business expected to reach double-digit EBITDA margin in 1-2 quarters as launch costs normalize.

• CapEx guidance: INR 450 crore for FY25, INR 250 crore for FY26, with major capacity additions largely completed.